Anonymous
Guest
Anonymous
Guest
ATHEROTECH IS NOT A RELATIONSHIP KILLER As long as we are upfront with our accounts and not play off the changes in billing as no big deal. It may come down to for out of network, doctors have to determine what tests are most crucial for thier patients. Atherotech has allowed doctors and patients the opportunity to have access to life saving, high end, markers that have changed many lives at an affordable price. It's basic economics. Cost has changed. With that, the patients and the doctors may opt to testing with Atherotech they can afford. It's up to us the reps to be transparent so that WE DO NOT KILL our relationships. Our offering which includes markers like cystatin C, Glycomark, Galecton 3 will now be less available as cost will play a larger role. Information from markers drs and patients receive from the VAP and Plac test are still very cost effective and vital to diagnosing and treating heart disease. We all know from our experience in the field via success stories from accounts how patient access to our testing has produced positive outcomes and better decision making surrounding patient care. Never lose sight of that. To the above threads, the job, the company, the future here is VERY UNCERTAIN. We need to do ourselves a favor and not concede to any BS corporate feeds us and focus on the very one thing that has made us successful. Our accounts. We need to be upfront, transparent and start looking for a new job. ASAP! It's been a great ride and look forward to seeing you all in a new market space.